[1] Sagen J. Cellular therapies for spinal cord injury: what will the FDA need to approve moving from the laboratory to the human[J]? J Rehabil Res Dev, 2003, 40(4Suppl 1): 71-79.
[2] Paul A, Ge Y, Prakash S, et al. Microencapsulated stemcells for tissue repairing: implications in cell-basedmyocardial therapy[J]. RegenMed, 2009, 4(5): 733-745.
[3] Abalovich AG, Bacqué MC, Grana D,et al. Pig pancreatic islet transplantation into spontaneously diabetic dogs[J]. Transplant Proc,2009,41(1): 328-330.
[4] Vériter S,Mergen J,Goebbels RM,et al.In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation[J]. Tissue Eng Part A, 2010, 16(5): 1503-1513.
[5] Kim B，Jeon TY，Oh YK, et al. Microfluidic production of semipermeable microcapsules by polymerization-induced phase separation[J]. Langmuir, 2015, 31(22): 6027-6034.
[6] Yim EK, Wan AC, Le Visage C, et al. Proliferation anddifferentiation ofhuman mesenchymal stem cellencapsulated in polyelectrolyte complexation fibrousscaffold[J]. Biomaterials, 2006, 27(36): 6111-6122.
[7] Chayosumrit M, Tuch B, Sidhu K. Alginate microcapsulefor propagation and directed differentiation of hESCs todefinitive endoderm[J]. Biomaterials, 2010, 31(3): 505-514.
[8]  Murua A, Portero A, Orive G, et al. Cell microencapsulationtechnology: towards clinical application[J]. J ControlRelease, 2008, 132(2): 76-83.
[9]  Zhang WJ, Li BG, Zhang C, et al. Biocompatibility and membrane strength of C3H10T1/2 cell-loaded alginate-based microcapsules[J]. Cytotherapy, 2008,10(1): 90-97.
[10] Chen ET, Yang XY, Ye P, et al. Development ofmicroencapsulated islettransplantation[J]. J Clin Rehabilit Tissue Eng Res, 2009, 13(3): 561-565.
[11] Kim YM，Kwak KH，Lim JO，et al.Reduction of allodynia by intrathecal transplantation of microencapsulated porcine chromaffincells[J]. Artificial Organs，2009, 33(3)：240-249.
[12] Herzberg U，Hama A，Sagen J.Spinal subarachnoidadrenal medullary transplants reduce hind paw swelling and peripheral nerve transport following formalin injection in rats[J]. Brain Res, 2008, 1198: 85-92.
[13] 薛毅珑，王振福，李新建， 等. 微囊化牛肾上腺嗜铬细胞脊髓蛛网膜下移植治疗慢性疼痛患者的初步观察[J]. 中华器官移植杂志, 2000, 21(6): 273-275.
[14] 杜智，周道标，李涛，等. 微囊化牛肾上腺嗜铬细胞移植治疗晚期癌痛研究[J]. 中国肿瘤临床，2003,30(11):761-765.
[15] 李涛，周道标，杜智，等. 用微囊牛肾上腺髓质细胞移植治疗恶性肿瘤疼痛研究[J]. 医学研究通讯，2002, 31(4):7-10.
[16] 张玮京，肖秀斌，何利敏，等. 海藻酸钠-聚赖氨酸-海藻酸钠微囊化牛肾上腺嗜铬细胞镇痛微胶囊镇痛过程中的不良反应：初步观察[J]. 中国临床康复，2004, 8(26)：5588-5589.
[17] 肖秀斌，张玮京，薛毅珑，等. APA-BCCs微胶囊移植对晚期癌症患者的镇痛效果评价[J]. 中国临床康复, 2004, 8(20)：3953-3954.
[18] Windus LC, Lineburg KE, Scott SE, et al. Lamellipodia mediate the heterogeneity of central olfactory ensheathing cell interactions[J]. Cell Mol Life Sci, 2010, 67(10):1735-1750.
[19] Van Riel D, Verdijk R, Kuiken T. The olfactory nerve:a shortcut for influenza and other viral diseases into the central nervous system[J]. J Pathol, 2015, 235(2): 277-287.
[20] Roet KC, Verhaagen J. Understanding the neural repair-promoting properties of olfactory ensheathing cells [J]. ExpNeurol, 2014, 261: 594-609.
[21] Luo Y, Zou Y, Yang L, et al. Transplantation of NSCs with OECs alleviates neuropathic pain associated with NGF downregulation in rats following spinal cord injury[J]. NeurosciLett, 2013, 549:103-108.
[22] Chou RH, Lu CY, Fan JR, et al. The potential therapeutic applications of olfactory ensheathing cells in regenerative medicine[J]. Cell Transplant, 2014, 23(4-5): 567-571.
[23] Ekberg JA, St John JA. Crucial roles for olfactory ensheathing cells and olfactory mucosal cells in the repair of damaged neural tracts[J].Anat Rec（Hoboken）, 2014, 297(1):121-128.
[24] Ramon Cueto A, Nieto Sampedro M. Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants[J]. J NeurolSci, 2011, 303: 67-74.
[25] Zengxu Liu，Fenggang Pan, Yu Qing, et al. Changes of expression of P2X3 receptor in rats with neuropathic pain after olfactory bulb tissue transplantation[J]. Ann Anat, 2014, 196(S1), 187.
[26] Wu A,Lauschke JL,Gorrie CA,et al. Delayed olfactory ensheathing cell transplants reduce nociception after dorsal root injury[J]. ExpNeurol,2011, 229(1):143-157.
[27] Zhao H, Yang BL, Liu ZX, et al. Microencapsulation improves inhibitory effects of transplanted olfactory ensheathing cells on pain after sciatic nerve injury[J]. Neural Regen Res, 2015, 10(8):1332-1337.
[28] 陈琳，江昭，黄红云，等. 嗅鞘细胞移植治疗脊髓损伤后顽固性神经性疼痛17例报道[J]. 中国康复理论与实践，2010, 16(2):146-148.
[29] 刘曾旭，王向东， 王航辉，等. 微囊化兔嗅球组织移植对脊髓损伤大鼠细胞凋亡的影响[J]. 中国组织工程研究与临床康复, 2007, 11(18): 3559-3562.
[30] 赵浩，刘曾旭. 微囊化嗅鞘细胞移植对背根神经节P2X2/3受体介导神经病理痛的作用研究[D]. 南昌大学医学院，2015.
[31] Mally P, Mishra R, Gandhi S, et al. Stereospecific regulation oftyrosinehydroxylase and proenkephalin genes by short-chainfatty acids in rat PC12 cells[J]. Pediatr Res, 2004, 55(5):847-854.
[32] 伍少玲，马超，燕铁斌. 微囊化PC12细胞的分泌特性及其致瘤性[J].中国组织工程研究与临床康复, 2008,12(36): 7041-7044.
[33] 伍少玲，马超，栗晓. 微囊化PC12 细胞蛛网膜下腔移植治疗慢性神经源性疼痛[J]. 中国组织工程研究, 2012, 16(38): 7135-7139.
[34] Campana WM. Schwann cells: activated peripheral glia and their role in neuropathic pain[J]. Brain BehavImmun, 2007, 21(5): 522-527.